Ezra Cohen, MD
University of California, San Diego · UCSD Moores Cancer Center (HNSCC) · University of Chicago
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ezra Cohen, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:34 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05153304 · Personalized Immunotherapy in Adults With Upper Gastrointestinal Tract CancersUniversity of California, San Diego · withdrawn · Cancer of Gastrointestinal Tract · principal investigator
- Ph1NCT03991741 · Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid TumorsGregory Daniels · terminated · Metastatic Melanoma, Locally Advanced Refractory/Recurrent Melanoma, Metastatic Head and Neck Cancer · principal investigator
- Ph2NCT03795610 · IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell CarcinomaAssuntina G. Sacco, MD · completed · Head and Neck Squamous Cell Carcinoma, Head and Neck Cancer, Head and Neck Carcinoma · principal investigator
- Ph2NCT02644122 · SF1126 in Recurrent or Progressive SCCHN and Mutations in PIK3CA Gene and/or PI-3 Kinase Pathway GenesEzra Cohen · terminated · Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma · principal investigator
- Ph1/Ph2NCT02521870 · A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaDynavax Technologies Corporation · terminated · Metastatic Melanoma, Head Neck Cancer · principal investigator
- Ph2NCT01836029 · Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCelgene · completed · Carcinoma, Squamous Cell of Head and Neck · study chair
- Ph2NCT01172470 · Phase II Trial of Pemetrexed-Based Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Previously Irradiated Head and Neck Cancer PatientsUniversity of Chicago · completed · Head and Neck Cancer · principal investigator
- Ph1NCT00708591 · Study of Rapamycin Plus Ketoconazole in Advanced CancersUniversity of Chicago · completed · Advanced Cancer · principal investigator
- Ph1NCT00667485 · Rapamycin Plus Bevacizumab in Advanced CancersUniversity of Chicago · completed · Advanced Cancer, Metastatic Cancer · principal investigator
- N/ANCT00619242 · The Effects of Sorafenib on Molecular Barrett's Esophagus CancerUniversity of Chicago · terminated · Esophageal Cancer · principal investigator
- Early Ph1NCT00583063 · Interaction Study of Rapamycin and Sunitinib in Patients With Advanced CancersUniversity of Chicago · completed · Solid Tumors · principal investigator
- Ph1NCT00449280 · Drug Interaction Study of Sorafenib and Rapamycin in Advanced MalignanciesUniversity of Chicago · completed · Advanced Solid Tumor · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.